105.11USD+0.75%Mkt Cap: 6.84B $P/E: 25.081d ago
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers …
Industry Peers
Drug Manufacturers - Specialty & Generic$65.19BUSDP/E 23.7
$22.46BUSDP/E 19.5
$20.18BUSD
$17.25BUSDP/E 26.4
$15.47BUSDP/E 179.2
$14.18BUSDP/E 29.7
$12.96BUSD
$8.93BUSDP/E 22.7
$7.80BUSD
$6.69BUSDP/E 442.8
$5.76BUSDP/E 48.8
$3.65BUSDP/E 19.0
$3.55BUSDP/E 11.3
$2.99BUSDP/E 20.9
$2.80BUSD
$2.52BUSDP/E 56.0
$2.35BUSDP/E 16.3
$2.40BUSDP/E 12.9
$2.31BUSD
$1.92BUSDP/E 19.4
$1.89BUSD
$1.86BUSDP/E 21.0
$1.71BUSD
$1.89BUSD
$1.67BUSD
$1.48BUSDP/E 17.5
$1.50BUSDP/E 124.1
$1.40BUSDP/E 14.8
$1.12BUSDP/E 35.4
$1.18BUSDP/E 17.6
$1.23BUSD
$1.06BUSDP/E Infinity
$1.02BUSD
$1.01BUSDP/E 196.9
$985.07MUSD
$918.60MUSDP/E 14.7
$873.22MUSDP/E 38.1
$875.69MUSDP/E 12.0
$819.46MUSDP/E Infinity
$668.29MUSD
$692.84MUSDP/E 161.5
$637.05MUSDP/E 6.2
$505.77MUSDP/E 14.3
$494.34MUSD
$447.41MUSD
$427.80MUSD
$396.78MUSD
$375.56MUSD
$370.76MUSD
$355.90MUSD
$343.56MUSD
$357.30MUSD
$320.48MUSDP/E 43.7
$294.94MUSDP/E 15.2
$303.08MUSDP/E 9.7
$273.62MUSDP/E 49.1
$285.23MUSD
$250.29MUSDP/E 47.6
$255.34MUSDP/E 12.7
$236.39MUSDP/E 53.0
$206.95MUSDP/E 10.3
$210.49MUSD
$195.77MUSD
$185.67MUSD
$182.70MUSDP/E 8.8
$164.20MUSD
$143.26MUSDP/E 18.3
$146.07MUSD
$133.59MUSD
$126.10MUSD
$119.66MUSDP/E 18.6
$114.77MUSD
$83.73MUSDP/E 12.0
$94.75MUSD
$72.66MUSD
$67.25MUSD
$70.06MUSD
$62.42MUSDP/E 52.6
$63.44MUSDP/E 21.8
$60.48MUSD
$63.41MUSD
$53.86MUSD
$50.62MUSD
$49.37MUSD
$48.31MUSD
$42.20MUSD
$41.16MUSD
$33.86MUSDP/E Infinity
$31.75MUSD
$27.85MUSD
$26.87MUSD
$23.61MUSDP/E 204.0
$23.18MUSD
$22.62MUSD
$22.15MUSD
$18.56MUSD
$17.65MUSD
$14.93MUSD
$13.84MUSDP/E 16.8
$14.21MUSD
$11.64MUSD
$11.91MUSD
$9.88MUSD
$8.99MUSD
$8.21MUSD
$8.13MUSD
$6.05MUSDP/E 3.7
$6.17MUSD
$6.48MUSDP/E 0.3
$5.84MUSD
$5.46MUSDP/E Infinity
$3.29MUSDP/E 1.6
$2.01MUSD
$1.93MUSD
$2.08MUSDP/E 35.5
$1.54MUSD
$668.8KUSD
$173.7KUSDP/E 0.0
$175USD
Indicators:|
Key Statistics
Company
Market Cap6.84B $
Enterprise Value6.97B $
Revenue (TTM)1.55B $
Gross Profit941.95M $
Net Income (TTM)233.56M $
Revenue/Share23.25 USD
Last Price105.11 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.2K
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINUS5165441032
Valuation
P/E (Trailing)25.08
P/E (Forward)16.56
PEG—
EV/EBITDA19.03
EV/Revenue4.51
P/S4.43
P/B5.64
EPS (TTM)4.19
EPS (Forward)6.35
52W Range
47.2590% of range111.86
52W High111.86 USD
52W Low47.25 USD
Profitability
Gross Margin61.10%
Oper. Margin21.65%
EBITDA Margin23.69%
Profit Margin15.15%
ROE21.43%
ROA10.49%
Growth
Revenue Growth1.20%
Earnings Growth76.50%
Cash Flow & Leverage
Operating CF390.14M $
CapEx (TTM)41.50M $
FCF Margin27.27%
FCF Yield6.16%
Net Debt127.17M $
Net Debt/EBITDA0.35
Balance Sheet
Debt/Equity0.57
Current Ratio2.83
Quick Ratio2.57
Book Value/Sh18.63 USD
Cash/Share7.658 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)110.75 USD
Upside (mean)+5.4%
Target Range94.00 USD – 129.00 USD
$94.00+5.4% to mean$129.00
# Analysts12
Ownership
Shares Out.65.11M
Float58.36M
Insiders2.09%
Institutions116.36%
Short Interest
Short Ratio6.3d
Short % Float12.95%
Short % Out.9.73%
Shares Short6.33M
Short (prev mo.)5.48M
Technical
SMA 50100.68 (+4.4%)
SMA 20075.44 (+39.3%)
Beta-0.06
S&P 52W Chg20.25%
Avg Vol (30d)852.32K
Avg Vol (10d)825.31K
Technical Indicators
RSI (14)52.6
MACD1.1163
MACD Signal1.9554
MACD Hist.-0.8391
BB Upper111.42 USD
BB Middle106.12 USD
BB Lower100.82 USD
BB Width9.98%
ATR (14)3.593 USD
Vol Ratio (20d)0.56x